Fundraising Fox
/Companies
Sign in

AlzProtect

Lille, FR · 2 known investors

Find your way into AlzProtect

Each arrow is one introduction. Sign up to fill in the first one.

117 people can intro you to Philippe

Ask Roel Bulthuis to introduce you to Philippe Verwaerde

You →Roel · together at Devgen →Philippe

Sign up to find every way you can get introduced to AlzProtect

  • Your email: who you already know at AlzProtect, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AlzProtect team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.

BiotechHealthtech

Founders & leadership

PVPhilippe Verwaerde
Philippe VerwaerdePresident & Chief Science OfficerPhilippe Verwaerde is President and Chief Science Officer of AlzProtect, a biotech company developing therapeutics for neurodegenerative diseases. He has held leadership roles in drug discovery across multiple therapeutic areas including inflammation, cardiovascular, anti-infectives, cancer, CNS, and metabolic diseases, with expertise spanning chemistry, biology, and translational development from preclinical through clinical phases.

Investors · 2

BpifrancereportedParis, Ile-De-France · $270K

How we know: funding news · Not right? Tell us

Frequently asked questions

What does AlzProtect do?
Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease. Its lead drug candidate targets multiple markers of neurodegeneration including amyloid beta peptide, Tau protein, neuroinflammation, and oxidative stress.
Who founded AlzProtect?
AlzProtect was founded by Philippe Verwaerde.
Who are AlzProtect's investors?
AlzProtect's investors include Xerys, Bpifrance.
Where is AlzProtect headquartered?
AlzProtect is headquartered in Lille, FR.